Suppr超能文献

在颅底脑膜瘤的多模态治疗中,根治性显微手术切除的作用。

The role of radical microsurgical resection in multimodal treatment for skull base meningioma.

机构信息

Department of Neurosurgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

出版信息

J Neurosurg. 2010 Nov;113(5):1072-8. doi: 10.3171/2010.2.JNS091118. Epub 2010 Mar 12.

Abstract

OBJECT

Because resection followed by timely stereotactic radiosurgery (SRS) is becoming a standard strategy for skull base meningiomas, the role of initial surgical tumor reduction in this combined treatment should be clarified.

METHODS

This study examined 161 patients with benign skull base meningiomas surgically treated at Osaka City University between January 1985 and December 2005. The mean follow-up period was 95.3 months. Patients were categorized into 3 groups based on the operative period and into 4 groups based on tumor location. Maximal resection was performed as first therapy throughout all periods. In the early period (1985-1994), in the absence of SRS, total excision of the tumor was intentionally performed for surgical cure of the disease. In the mid and late periods (1995-2000 and 2001-2005), small parts of the tumor invading critical neurovascular structures were left untouched to obtain good functional results. Residual tumors with high proliferation potential (Ki 67 index > 4%) or with progressive tendencies were treated with SRS. The extent of initial tumor resection, recurrence rate, Karnofsky Performance Scale score, and complication rate were investigated in each group.

RESULTS

The mean tumor equivalent diameter of residual tumors was 3.67 mm in the no-recurrence group and 11.7 mm in the recurrence group. The mean tumor resection rate (TRR) was 98.5% in the no-recurrence group and 90.1% in the recurrence group. A significant relationship was seen between postoperative tumor size, TRR, and recurrence rate (p < 0.001), but the recurrence rate showed no significant relationship with any other factors such as operative period (p = 0.48), tumor location (p = 0.76), or preoperative tumor size (p = 0.067). The mean TRR was maintained throughout all operative periods, but the complication rate was lowest and postoperative Karnofsky Performance Scale score was best in the late period (p < 0.001 each). Late-period results were as follows: mean TRR, 97.9%; mortality rate, 0%; and severe morbidity rate, 0%. Stereotactic radiosurgery procedures were added in 27 cases (16.8%) across all periods. Throughout all follow-up periods, 158 tumors were satisfactorily controlled by maximal possible excision alone or in combination with adequate SRS.

CONCLUSIONS

The combination of maximal possible resection and additional SRS improves functional outcomes in patients with skull base meningioma. A TRR greater than 97% in volume can be achieved with satisfactory functional preservation and will lead to excellent tumor control in combined treatment of skull base meningioma.

摘要

目的

由于切除后及时进行立体定向放射外科(SRS)治疗已成为颅底脑膜瘤的标准治疗策略,因此应明确在这种联合治疗中初始手术肿瘤切除的作用。

方法

本研究回顾性分析了 1985 年 1 月至 2005 年 12 月在大阪城市大学接受手术治疗的 161 例良性颅底脑膜瘤患者的临床资料。平均随访时间为 95.3 个月。根据手术时间将患者分为 3 组,根据肿瘤位置分为 4 组。所有时期均行最大限度切除术作为初始治疗。在早期(1985-1994 年),由于缺乏 SRS,为了治愈疾病,我们故意行肿瘤全切除。在中晚期(1995-2000 年和 2001-2005 年),我们保留了部分侵犯重要神经血管结构的肿瘤,以获得良好的功能结果。对具有高增殖潜能(Ki-67 指数>4%)或进展趋势的残留肿瘤行 SRS 治疗。研究了每组的初始肿瘤切除程度、复发率、Karnofsky 表现量表评分和并发症发生率。

结果

无复发组的残余肿瘤等效直径的平均值为 3.67mm,复发组为 11.7mm。无复发组的肿瘤切除率(TRR)平均值为 98.5%,复发组为 90.1%。术后肿瘤大小、TRR 和复发率之间存在显著关系(p<0.001),但复发率与手术时间(p=0.48)、肿瘤位置(p=0.76)或术前肿瘤大小(p=0.067)等其他因素均无显著关系。所有手术时期的平均 TRR 均保持稳定,但晚期的并发症发生率最低,术后 Karnofsky 表现量表评分最佳(均 p<0.001)。晚期结果如下:平均 TRR 为 97.9%;死亡率为 0%;严重发病率为 0%。在所有时期,立体定向放射外科治疗共 27 例(16.8%)。在所有随访期间,158 例肿瘤通过最大限度切除术单独或与适当的 SRS 联合治疗得到了满意的控制。

结论

最大限度切除联合 SRS 可改善颅底脑膜瘤患者的功能预后。体积上的 TRR 大于 97%,同时保持良好的功能保存,将导致颅底脑膜瘤联合治疗中获得良好的肿瘤控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验